Marina Ionela Nedea

Dr. Marina Ionela Nedea

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
ACAna Cernega
Ana Cernega
DNDragoș Nicolae Nicolescu
Dragoș Nicolae Nicolescu
MIMarina Imre
Marina Imre
ARALEXANDRA RIPSZKY
ALEXANDRA RIPSZKY
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
SPSilviu Mirel Pițuru
Silviu Mirel Pițuru
Our professional activity is constantly under pressure from a multitude of elements and factors that can be classified into the four components of the VUCA phenomenon—volatility, uncertainty, complexity, and ambiguity—components that define the turbulence and challenges of the external environment. Considering the general elements of this phenomenon, we designed a new VUCA dimension specific to the healthcare field within which we have identified and analyzed all the factors that can influence the main actors of the doctor–patient relationship and the effects that can occur within the healthcare system in which this relationship is born. In this context, we generated the VUCA treatment in healthcare capable of mitigating the impact of this phenomenon; this treatment involves essential elements in overcoming possible crises and vulnerabilities of the medical profession. The VUCA treatment in healthcare requires combating volatility, uncertainty, complexity, and ambiguity through vision, understanding, clarity, and agility, which are grounded in the doctor’s need to acquire cross-functional competencies (soft skills). These competencies are applicable by using functional mechanisms and techniques that support the doctor in developing adaptability and anticipation skills, understanding the patient’s needs and addressing them, and ensuring the functionality and efficiency of the healthcare system by transferring these elements from micro-management to macro-management levels.

20 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Miruna Maria ApetroaeiMiruna Maria Apetroaei
Miruna Maria Apetroaei
Bruno Stefan VelescuBruno Stefan Velescu
Bruno Stefan Velescu
Marina Ionela NedeaMarina Ionela Nedea
Marina Ionela Nedea
Cristina Elena Dinu-PîrvuCristina Elena Dinu-Pîrvu
Cristina Elena Dinu-Pîrvu
Doina DrǎgǎnescuDoina Drǎgǎnescu
Doina Drǎgǎnescu
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
Human immunodeficiency virus (HIV) is a significant global health issue that affects a substantial number of individuals across the globe, with a total of 39 million individuals living with HIV/AIDS. ART has resulted in a reduction in HIV-related mortality. Nevertheless, the issue of medication resistance is a significant obstacle in the management of HIV/AIDS. The unique genetic composition of HIV enables it to undergo rapid mutations and adapt, leading to the emergence of drug-resistant forms. The development of drug resistance can be attributed to various circumstances, including noncompliance with treatment regimens, insufficient dosage, interactions between drugs, viral mutations, preexposure prophylactics, and transmission from mother to child. It is therefore essential to comprehend the molecular components of HIV and the mechanisms of antiretroviral medications to devise efficacious treatment options for HIV/AIDS.

19 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
SMSimona Marinescu
Simona Marinescu
Miruna Maria ApetroaeiMiruna Maria Apetroaei
Miruna Maria Apetroaei
Marina Ionela NedeaMarina Ionela Nedea
Marina Ionela Nedea
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
Bruno Stefan VelescuBruno Stefan Velescu
Bruno Stefan Velescu
Denisa Ioana UdeanuDenisa Ioana Udeanu
Denisa Ioana Udeanu
It is widely acknowledged that the ketogenic diet (KD) has positive physiological effects as well as therapeutic benefits, particularly in the treatment of chronic diseases. Maintaining nutritional ketosis is of utmost importance in the KD, as it provides numerous health advantages such as an enhanced lipid profile, heightened insulin sensitivity, decreased blood glucose levels, and the modulation of diverse neurotransmitters. Nevertheless, the integration of the KD with pharmacotherapeutic regimens necessitates careful consideration. Due to changes in their absorption, distribution, metabolism, or elimination, the KD can impact the pharmacokinetics of various medications, including anti-diabetic, anti-epileptic, and cardiovascular drugs. Furthermore, the KD, which is characterised by the intake of meals rich in fats, has the potential to impact the pharmacokinetics of specific medications with high lipophilicity, hence enhancing their absorption and bioavailability. However, the pharmacodynamic aspects of the KD, in conjunction with various pharmaceutical interventions, can provide either advantageous or detrimental synergistic outcomes. Therefore, it is important to consider the pharmacokinetic and pharmacodynamic interactions that may arise between the KD and various drugs. This assessment is essential not only for ensuring patients’ compliance with treatment but also for optimising the overall therapeutic outcome, particularly by mitigating adverse reactions. This highlights the significance and necessity of tailoring pharmacological and dietetic therapies in order to enhance the effectiveness and safety of this comprehensive approach to managing chronic diseases.

Verified
Journal Article
Open access
PDF file
Miruna Maria ApetroaeiMiruna Maria Apetroaei
Miruna Maria Apetroaei
PFPersefoni Fragkiadaki
Persefoni Fragkiadaki
Bruno Stefan VelescuBruno Stefan Velescu
Bruno Stefan Velescu
SBStella Baliou
Stella Baliou
ERElisavet Renieri
Elisavet Renieri
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
Telomeres are part of chromatin structures containing repeated DNA sequences, which function as protective caps at the ends of chromosomes and prevent DNA degradation and recombination, thus ensuring the integrity of the genome. While telomere length (TL) can be genetically inherited, TL shortening has been associated with ageing and multiple xenobiotics and bioactive substances. TL has been characterised as a reliable biomarker for the predisposition to developing chronic pathologies and their progression. This narrative review aims to provide arguments in favour of including TL measurements in a complex prognostic and diagnostic panel of chronic pathologies and the importance of assessing the effect of different pharmacologically active molecules on the biology of telomeres. Medicines used in the management of cardiovascular diseases, diabetes, schizophrenia, hormone replacement therapy at menopause, danazol, melatonin, and probiotics have been studied for their positive protective effects against TL shortening. All these classes of drugs are analysed in the present review, with a particular focus on the molecular mechanisms involved.

27 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
EEEce Ergin
Ece Ergin
ADAna Dascalu
Ana Dascalu
DSDaniela Stana
Daniela Stana
LTLaura Carina Tribus
Laura Carina Tribus
Andreea Letitia ArseneAndreea Letitia Arsene
Andreea Letitia Arsene
BCBogdan Mihai Cristea
Bogdan Mihai Cristea
Background: Diabetic macular edema (DME) is the leading cause of vision impairment in diabetic patients, with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections being the first-line therapy. However, one-third of patients exhibit persistent DME despite treatment, suggesting additional pathogenic factors. This study aimed to evaluate the predictive value of complete blood count (CBC)-based inflammation indexes and optical coherence tomography (OCT) parameters in determining early anti-VEGF treatment effectiveness in DME. Methods: One hundred and four naïve patients with DME, treated with 0.05 mL of intravitreal aflibercept were retrospectively analyzed. Blood parameters analyzed included neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). Baseline OCT biomarkers included subretinal fluid (SRF), intraretinal cysts (IRC), hyperreflective retinal spots (HRS), and disorganization of retinal inner layers (DRIL). Treatment response was defined as a minimum 10% reduction in central macular thickness (CMT) at one month post-injection. Results: NLR, MLR, PLR, and SII were significantly higher in non-responders (p < 0.001), but their predictive value was fair, with an area under the ROC curve ranging between 0.704 (MLR) and 0.788 (SII). A multivariate model including SII, initial CMT, and the presence of IRC showed an excellent prediction value for early anatomical response (AUC ROC of 0.911). At the same time, lower PLR, DRIL, SRF, and the absence of HRF were correlated with early gain in BCVA. Conclusions: CBC-derived inflammation indices and OCT biomarkers have prognostic value in predicting early response to anti-VEGF therapy in DME in terms of functional and anatomical outcomes. These findings could help identify poor responders and guide personalized treatment strategies.

9 April 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Marina Ionela NedeaMarina Ionela Nedea
Marina Ionela Nedea
CBCarmellina Daniela Badiceanu
Carmellina Daniela Badiceanu
IGIrina Gheorghe
Irina Gheorghe
IMIoana Cristina Marinas
Ioana Cristina Marinas
RPRadu Pericleanu
Radu Pericleanu
Bruno Stefan VelescuBruno Stefan Velescu
Bruno Stefan Velescu
Nosocomial fungal infections caused by Candida auris pose a threat to public health due to their increased resistance to common antifungal drugs. Four thiourea derivatives of 2-thiophenecarboxylic acid were evaluated for their antifungal and antioxidant activity. The antifungal activity of the compounds was tested against strains of C. auris isolated from a hospital in Romania. With a notable inhibitory effect on C. auris biofilm growth and microbial adherence, the ortho-methylated derivative (SB2) showed the highest antifungal activity. Furthermore, emphasizing the impact of structural factors on the electron-donating capacity of these compounds, antioxidant activity assays (DPPH, FRAP, TEAC and CUPRAC) identified the SB2 compound as having the highest antihemolytic and antioxidant effects. The low cytotoxicity validated by hemocompatibility assays makes these compounds options for antifungal treatment. The results show that antifungal and antioxidant action is greatly influenced by structural modifications, especially the position of the methyl group on the aromatic ring. The possible clinical uses of these molecules as drugs for the treatment of multidrug-resistant C. auris infections needs further investigation.